Please use this identifier to cite or link to this item:
Authors: Salluh, Jorge Ibrain Figueira
Souza-Dantas, Vicente Cés de
Martin-Loeches, Ignacio
Lisboa, Thiago
Rabello, Ligia Sarmet Cunha Farah
Saad, Nseir
Póvoa, Pedro
Title: Ventilator-associated tracheobronchitis: an update
Keywords: Critical care;Mortality;Nosocomial infection;Pneumonia;Healthcare-associated pneumonia;Ventilator-associated;Ventilator-associated tracheobronchitis
Issue Date: 2019
Citation: SALLUH, J. I. F. Ventilator-associated tracheobronchitis: an update. Rev. bras. ter. intensiva, v. 31, n. 4, p. 541-547, out./dez. 2019. Disponível em: Acesso em: 27 jul. 2021.
Abstract: Ventilator-associated lower respiratory tract infection is one of the most frequent complications in mechanically ventilated patients. Ventilator-associated tracheobronchitis has been considered a disease that does not warrant antibiotic treatment by the medical community for many years. In the last decade, several studies have shown that tracheobronchitis could be considered an intermediate process that leads to ventilator-associated pneumonia. Furthermore, ventilator-associated tracheobronchitis has a limited impact on overall mortality but shows a significant association with increased patient costs, length of stay, antibiotic use, and duration of mechanical ventilation. Although we still need clear evidence, especially concerning treatment modalities, the present study on ventilator-associated tracheobronchitis highlights that there are important impacts of including this condition in clinical management and epidemiological and infection surveillance.
Appears in Collections:Artigo de Periódico (PPGSDH)

Files in This Item:
File Description SizeFormat 
Ventilator-associated tracheobronchitis_RBTI.pdfOpen Access130.58 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.